Published in Clin Exp Immunol on June 01, 2005
Risk factors for renal cell carcinoma in the VITAL study. J Urol (2013) 1.62
Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway. Am J Pathol (2009) 1.00
Association of hepatitis C virus infection with prevalence and development of kidney disease. Am J Kidney Dis (2008) 0.96
Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden. Eur J Cancer Prev (2011) 0.89
Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis. Hepatology (2012) 0.86
Hepatitis C virus, cryoglobulinemia, and kidney: novel evidence. Scientifica (Cairo) (2012) 0.83
Chronic hepatitis C infection as a risk factor for renal cell carcinoma. Dig Dis Sci (2015) 0.83
Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Dig Dis Sci (2015) 0.82
Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis. Am J Nephrol (2010) 0.81
Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. World J Gastroenterol (2015) 0.80
Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol (2016) 0.80
De Novo Fibrillary Glomerulonephritis (FGN) in a Renal Transplant with Chronic Hepatitis C. Case Rep Transplant (2013) 0.76
Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir. AIDS Res Hum Retroviruses (2013) 0.76
Microalbuminuria in hepatitis C-genotype 4: effect of pegylated interferon and ribavirin. World J Gastroenterol (2010) 0.76
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? World J Hepatol (2016) 0.75
Hepatitis C Virus and Nonliver Solid Cancers: Is There an Association between HCV and Cancers of the Pancreas, Thyroid, Kidney, Oral Cavity, Breast, Lung, and Gastrointestinal Tract? Gastroenterol Res Pract (2017) 0.75
Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57
Binding of hepatitis C virus to CD81. Science (1998) 12.40
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J (2002) 7.93
Viral hepatitis C. Lancet (2003) 5.81
Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol (1993) 3.34
DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci U S A (2001) 2.86
DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem (2003) 2.82
Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol (1999) 2.59
Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med Microbiol Immunol (1993) 2.36
Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology (2002) 2.21
Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol (2001) 1.84
Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology (2004) 1.73
Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology (1997) 1.71
Hepatitis C and renal disease: an update. Am J Kidney Dis (2003) 1.65
Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood (2002) 1.58
Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J Immunol (2001) 1.51
Fcgamma receptor-like activity of hepatitis C virus core protein. J Biol Chem (2003) 1.27
Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J Virol (2003) 1.18
RNA amplification in brain tissues. Neurochem Res (2002) 1.11
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. Clin Exp Immunol (2003) 1.08
Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology (1995) 0.99
Microdissection of histologic sections: past, present, and future. Adv Anat Pathol (2002) 0.99
Renal manifestations of hepatitis C infection. Am J Med (1999) 0.98
Biophysical characterization of hepatitis C virus core protein: implications for interactions within the virus and host. FEBS Lett (2004) 0.96
Detection of hepatitis C virus core protein in the glomeruli of patients with membranous glomerulonephritis. Clin Nephrol (1996) 0.91
Hepatitis C virus-associated tubulointerstitial injury. Am J Kidney Dis (2003) 0.90
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay. J Viral Hepat (2004) 0.89
Hepatitis C virus RNA in kidney biopsies from infected patients with renal diseases. J Viral Hepat (2000) 0.82
Application of laser capture microdissection to proteomics. Methods Enzymol (2002) 0.78
Glomerular injury associated with hepatitis C infection: a correlation with blood and tissue HCV-PCR. Semin Diagn Pathol (2002) 0.77
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet (1999) 4.38
Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol (2000) 2.89
A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant (2008) 2.81
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int (2007) 2.31
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood (1999) 2.30
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood (1999) 2.28
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet (2000) 2.12
Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol (1994) 2.01
Antiangiogenesis is produced by nontoxic doses of vinblastine. Blood (1999) 1.84
Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology (1997) 1.71
Primary renal lymphoma does exist: case report and review of the literature. J Nephrol (2001) 1.63
IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection. Am J Transplant (2011) 1.62
The dynamics of kidney donation: viewpoints from the donor, the recipients, and the transplant team. Kidney Int (2008) 1.58
Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin Exp Allergy (2001) 1.53
Immune complexes in rheumatoid synovitis: a mixed staining immunofluorescence study. Immunology (1970) 1.48
Italian cross-sectional growth charts for height, weight and BMI (6-20 y). Eur J Clin Nutr (2002) 1.46
FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia. Am J Transplant (2006) 1.45
[2004 census of the Italian nephrology and dialysis units]. G Ital Nefrol (2007) 1.40
Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors. Ann Ital Med Int (2001) 1.40
Granulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors: evidence for a synergistic hematologic toxicity. Am J Med (1995) 1.40
[Pro and anti-neoplastic effects of immunosuppressive drug in renal transplantation]. G Ital Nefrol (2006) 1.38
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. Semin Liver Dis (2000) 1.28
Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS (1996) 1.28
Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum (1999) 1.27
Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura. Nephrol Dial Transplant (1997) 1.27
Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol (1996) 1.24
Clearance kinetics and fate of macromolecular IgA in patients with IgA nephropathy. Lab Invest (1989) 1.23
Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest (1991) 1.22
The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int J Dev Biol (1996) 1.21
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int (2000) 1.20
Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis. Blood (2001) 1.20
The role of the vascular phase in solid tumor growth: a historical review. Neoplasia (1999) 1.20
Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol (2001) 1.19
Immune complex cryoglobulinaemia in lepromatous leprosy: a pathogenetic approach to some clinical features of leprosy. Clin Exp Immunol (1971) 1.19
Acute renal failure during intermittent rifampicin therapy. Nephron (1973) 1.19
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene (2007) 1.18
The role of mast cells in tumour angiogenesis. Br J Haematol (2001) 1.18
Bortezomib as an antitumor agent. Curr Pharm Biotechnol (2006) 1.17
Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma. Br J Haematol (2001) 1.16
Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol (1998) 1.15
Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: potential role in liver injury. Hepatology (1995) 1.14
Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients. Clin Exp Immunol (1996) 1.13
The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. Curr Pharm Biotechnol (2000) 1.12
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer (1999) 1.10
Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis. Clin Exp Immunol (2008) 1.09
Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer (1993) 1.09
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. Clin Exp Immunol (2003) 1.08
Waldenström's macroglobulinaemia with anti-IgG activity: a series of five cases. Clin Exp Immunol (1970) 1.08
Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood (1995) 1.07
Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study. Eur J Haematol (1996) 1.07
Long term follow-up of women with hypertension in pregnancy. Int J Gynaecol Obstet (1988) 1.07
Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma. Histopathology (2007) 1.06
In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma. Cancer (1997) 1.06
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Br J Cancer (1999) 1.04
Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis. Clin Nephrol (1982) 1.04
Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood (1997) 1.04
alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. Exp Hematol (2001) 1.04
Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study. Kidney Int (1996) 1.03
Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab (1996) 1.03
Toward a chronoimmunomodulation by cefodizime in multiple myeloma and chronic uremia. Chronobiologia (1988) 1.03
Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am J Hematol (1995) 1.01
Antibody deficiency in paraproteinemia. Acta Med Scand (1966) 1.01
Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood (1998) 1.01
Postnatal vasculogenesis. Mech Dev (2001) 1.00
Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer (2000) 1.00
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. Am J Pathol (1996) 1.00
Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) (2007) 0.99
Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology (1995) 0.99
Hepatitis C virus c100 antigen in liver tissue from patients with acute and chronic infection. Hepatology (1993) 0.99
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic. J Intern Med (2010) 0.99
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate. J Immunol Methods (1990) 0.98
The occurrence of serum 7S IgM in diseases associated with immunoglobulin abnormalities. Int Arch Allergy Appl Immunol (1970) 0.98
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res (1998) 0.97
Analbuminemia: report of a case and review of the literature. Vox Sang (1980) 0.97
Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies. Clin Exp Immunol (2006) 0.96
Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia. Clin Exp Immunol (2007) 0.96
Ischemia-reperfusion injury-induced abnormal dendritic cell traffic in the transplanted kidney with delayed graft function. Kidney Int (2007) 0.96
Bence Jones proteinuria in benign monoclonal gammapathies. Incidence and characteristics. Acta Med Scand (1968) 0.95
Screening of diabetic children for coeliac disease with antigliadin antibodies and HLA typing. Arch Dis Child (1991) 0.95
Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia (2003) 0.95
Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer (2003) 0.95
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev (2004) 0.95
Autoreactivity in HIV-1 infection: the role of molecular mimicry. Clin Immunol Immunopathol (1995) 0.95
Obesity in kidney transplantation affects renal function but not graft and patient survival. Transplant Proc (2011) 0.93
Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients. J Clin Oncol (1991) 0.93
PDGF-mediated activation of phosphatidylinositol 3 kinase in human mesangial cells. Kidney Int (1994) 0.93
Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game? Kidney Int (1997) 0.93